Ovid Therapeutics Stock Performance

OVID Stock  USD 1.56  0.01  0.65%   
On a scale of 0 to 100, Ovid Therapeutics holds a performance score of 4. The company holds a Beta of 2.37, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Ovid Therapeutics will likely underperform. Please check Ovid Therapeutics' total risk alpha, expected short fall, price action indicator, as well as the relationship between the value at risk and daily balance of power , to make a quick decision on whether Ovid Therapeutics' historical price patterns will revert.

Risk-Adjusted Performance

Soft

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Ovid Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain forward indicators, Ovid Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
1
Ovid Therapeutics Announces Planned Leadership Succession and Reports Business Updates and Third Quarter 2025 Financial Results
11/12/2025
2
Historical volatility pattern of Ovid Therapeutics Inc. visualized - July 2025 Setups Expert-Curated Trade Recommendations - newser.com
11/18/2025
3
Ovid Therapeutics HC Wainwright Raises Price Target to 2.00 OVID Stock News - GuruFocus
11/24/2025
4
Ovid Therapeutics Stock Drop Looks Sharp, But How Deep Can It Go - Trefis
12/03/2025
5
Disposition of 1250 shares by Takeda Pharmaceutical Co Ltd of Ovid Therapeutics subject to Rule 16b-3
12/08/2025
6
H.C. Wainwright Maintains Ovid Therapeutics With Buy Rating, Cuts Target Price to 2 -
12/09/2025
7
Disposition of tradable shares by Levin Jeremy M of Ovid Therapeutics subject to Rule 16b-3
12/15/2025
8
12 Health Care Stocks Moving In Mondays Intraday Session
12/22/2025
9
Ovid Therapeutics Raised to Hold at Wall Street Zen
12/29/2025
10
Acquisition by Margaret Alexander of 890000 shares of Ovid Therapeutics at 1.76 subject to Rule 16b-3
01/02/2026
11
Ovid Therapeutics Receives Consensus Recommendation of Buy from Analysts - MarketBeat
01/09/2026
12
Disposition of 34017 shares by Rakhit Amit of Ovid Therapeutics at 3.71 subject to Rule 16b-3
01/13/2026
Begin Period Cash Flow29 M
Total Cashflows From Investing Activities54.6 M

Ovid Therapeutics Relative Risk vs. Return Landscape

If you would invest  138.00  in Ovid Therapeutics on November 2, 2025 and sell it today you would earn a total of  18.00  from holding Ovid Therapeutics or generate 13.04% return on investment over 90 days. Ovid Therapeutics is currently generating 0.3766% in daily expected returns and assumes 6.0336% risk (volatility on return distribution) over the 90 days horizon. In different words, 54% of stocks are less volatile than Ovid, and 93% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Ovid Therapeutics is expected to generate 8.07 times more return on investment than the market. However, the company is 8.07 times more volatile than its market benchmark. It trades about 0.06 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.07 per unit of risk.

Ovid Therapeutics Target Price Odds to finish over Current Price

The tendency of Ovid Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 1.56 90 days 1.56 
about 47.65
Based on a normal probability distribution, the odds of Ovid Therapeutics to move above the current price in 90 days from now is about 47.65 (This Ovid Therapeutics probability density function shows the probability of Ovid Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.37 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Ovid Therapeutics will likely underperform. Additionally Ovid Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Ovid Therapeutics Price Density   
       Price  

Predictive Modules for Ovid Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ovid Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.081.547.57
Details
Intrinsic
Valuation
LowRealHigh
0.112.118.14
Details
Naive
Forecast
LowNextHigh
0.031.497.52
Details
6 Analysts
Consensus
LowTargetHigh
3.684.054.49
Details

Ovid Therapeutics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Ovid Therapeutics is not an exception. The market had few large corrections towards the Ovid Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Ovid Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Ovid Therapeutics within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.04
β
Beta against Dow Jones2.37
σ
Overall volatility
0.17
Ir
Information ratio 0.01

Ovid Therapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ovid Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ovid Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Ovid Therapeutics had very high historical volatility over the last 90 days
Ovid Therapeutics may become a speculative penny stock
Ovid Therapeutics has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 566 K. Net Loss for the year was (26.43 M) with profit before overhead, payroll, taxes, and interest of 6.61 M.
Ovid Therapeutics currently holds about 152.37 M in cash with (55.96 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.16, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Ovid Therapeutics has a frail financial position based on the latest SEC disclosures
Latest headline from news.google.com: Ovid Therapeutics Receives Consensus Recommendation of Buy from Analysts - MarketBeat

Ovid Therapeutics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Ovid Stock often depends not only on the future outlook of the current and potential Ovid Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ovid Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding70.9 M
Cash And Short Term Investments53.1 M

Ovid Therapeutics Fundamentals Growth

Ovid Stock prices reflect investors' perceptions of the future prospects and financial health of Ovid Therapeutics, and Ovid Therapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ovid Stock performance.

About Ovid Therapeutics Performance

By analyzing Ovid Therapeutics' fundamental ratios, stakeholders can gain valuable insights into Ovid Therapeutics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Ovid Therapeutics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Ovid Therapeutics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.26)(0.27)
Return On Capital Employed(0.87)(0.92)
Return On Assets(0.26)(0.27)
Return On Equity(0.45)(0.47)

Things to note about Ovid Therapeutics performance evaluation

Checking the ongoing alerts about Ovid Therapeutics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Ovid Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Ovid Therapeutics had very high historical volatility over the last 90 days
Ovid Therapeutics may become a speculative penny stock
Ovid Therapeutics has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 566 K. Net Loss for the year was (26.43 M) with profit before overhead, payroll, taxes, and interest of 6.61 M.
Ovid Therapeutics currently holds about 152.37 M in cash with (55.96 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.16, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Ovid Therapeutics has a frail financial position based on the latest SEC disclosures
Latest headline from news.google.com: Ovid Therapeutics Receives Consensus Recommendation of Buy from Analysts - MarketBeat
Evaluating Ovid Therapeutics' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Ovid Therapeutics' stock performance include:
  • Analyzing Ovid Therapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ovid Therapeutics' stock is overvalued or undervalued compared to its peers.
  • Examining Ovid Therapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Ovid Therapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ovid Therapeutics' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Ovid Therapeutics' stock. These opinions can provide insight into Ovid Therapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Ovid Therapeutics' stock performance is not an exact science, and many factors can impact Ovid Therapeutics' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Ovid Stock analysis

When running Ovid Therapeutics' price analysis, check to measure Ovid Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ovid Therapeutics is operating at the current time. Most of Ovid Therapeutics' value examination focuses on studying past and present price action to predict the probability of Ovid Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ovid Therapeutics' price. Additionally, you may evaluate how the addition of Ovid Therapeutics to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Money Managers
Screen money managers from public funds and ETFs managed around the world
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Insider Screener
Find insiders across different sectors to evaluate their impact on performance